ChristianKl
1yr ago
If we have another pandemic it matters whether or not we spend resources on studies for generics like Ivermectin and Ivermectin in particular. With the current state of affairs, we likely won't run high-quality studies for Ivermectin to be used on a new virus.
ChristianKl
1yr ago
We had a time when the best meta-analysis as evaluated on LessWrong was pro-Ivermectin and the institutions were anti-Ivermectin.
The question of whether to follow the highest quality published metastudies or the institutions in cases where those differ is an important one. If the highest quality published metastudy was right about ivermectin and the institutions wrong that's a lesson for the future.
If the institutions are wrong and generally suppress the use of generics for important illnesses that suggests we should invest more money into studying whether generics are useful for problems that arise.
Lastly, if Ivermectin works for COVID there's a decent chance that it also works for other viruses. If we have another pandemic it's important to know whether we should run trials to test whether Ivermectin helps or don't run those trials.
Scott reward for interacting with him is that Scott was able to fix an error in his article. To the extent that Scott cares about the truth that's valuable.
More options
Context Copy link